| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Proximal | 19 | 2021 | 386 | 1.080 |
Why?
|
| Kidney | 20 | 2021 | 7070 | 0.760 |
Why?
|
| Reperfusion Injury | 13 | 2021 | 1043 | 0.620 |
Why?
|
| Membrane Proteins | 13 | 2021 | 7850 | 0.600 |
Why?
|
| Acute Kidney Injury | 12 | 2020 | 1943 | 0.590 |
Why?
|
| Kidney Tubules | 9 | 2020 | 453 | 0.580 |
Why?
|
| Tyrosine 3-Monooxygenase | 10 | 1997 | 367 | 0.490 |
Why?
|
| Cell Adhesion Molecules | 5 | 2013 | 1610 | 0.480 |
Why?
|
| Kidney Diseases | 7 | 2022 | 2100 | 0.470 |
Why?
|
| Epithelial Cells | 14 | 2019 | 3684 | 0.440 |
Why?
|
| Heart Transplantation | 8 | 2021 | 3301 | 0.440 |
Why?
|
| Glomerulonephritis | 2 | 2012 | 331 | 0.430 |
Why?
|
| Cisplatin | 8 | 2022 | 1654 | 0.390 |
Why?
|
| Lymph Nodes | 5 | 2022 | 3457 | 0.360 |
Why?
|
| Phagocytosis | 3 | 2015 | 1517 | 0.360 |
Why?
|
| Receptors, Virus | 3 | 2015 | 651 | 0.350 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3692 | 0.330 |
Why?
|
| Diabetic Nephropathies | 3 | 2021 | 968 | 0.290 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4408 | 0.270 |
Why?
|
| Immunity, Cellular | 1 | 2012 | 1557 | 0.260 |
Why?
|
| Graft Rejection | 5 | 2021 | 4504 | 0.260 |
Why?
|
| Cysteine | 5 | 2005 | 898 | 0.260 |
Why?
|
| Oxidative Stress | 5 | 2014 | 3140 | 0.250 |
Why?
|
| Tryptophan Hydroxylase | 4 | 1995 | 93 | 0.230 |
Why?
|
| Heterocyclic Compounds | 1 | 2005 | 245 | 0.230 |
Why?
|
| Graft Survival | 6 | 2021 | 3904 | 0.220 |
Why?
|
| Animals | 72 | 2022 | 168775 | 0.220 |
Why?
|
| Nephrotic Syndrome | 3 | 2005 | 380 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 12 | 2021 | 6215 | 0.210 |
Why?
|
| Lymphocyte Activation | 3 | 2017 | 5503 | 0.210 |
Why?
|
| Rats | 32 | 2013 | 23709 | 0.210 |
Why?
|
| Hydrocarbons, Fluorinated | 5 | 2005 | 40 | 0.200 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 1132 | 0.200 |
Why?
|
| Drug Delivery Systems | 3 | 2019 | 2210 | 0.200 |
Why?
|
| Serpins | 2 | 2020 | 244 | 0.190 |
Why?
|
| Chemokine CCL2 | 2 | 2015 | 602 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 3 | 1996 | 871 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 791 | 0.190 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 58 | 0.190 |
Why?
|
| COUP Transcription Factor II | 1 | 2021 | 19 | 0.190 |
Why?
|
| Fibrosis | 8 | 2021 | 2073 | 0.190 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2021 | 618 | 0.190 |
Why?
|
| Nanoparticles | 4 | 2018 | 1965 | 0.180 |
Why?
|
| Up-Regulation | 7 | 2019 | 4133 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2021 | 63 | 0.180 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 760 | 0.180 |
Why?
|
| Mice | 36 | 2022 | 81821 | 0.180 |
Why?
|
| Rats, Inbred F344 | 5 | 2005 | 820 | 0.180 |
Why?
|
| Receptors, Cell Surface | 2 | 2015 | 2815 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 19 | 2021 | 22334 | 0.170 |
Why?
|
| Stromal Cells | 2 | 2022 | 1332 | 0.170 |
Why?
|
| Esophageal Neoplasms | 2 | 2022 | 1659 | 0.160 |
Why?
|
| Cyclin G1 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 2504 | 0.160 |
Why?
|
| Endothelium, Lymphatic | 1 | 2018 | 63 | 0.160 |
Why?
|
| Cell Compartmentation | 1 | 2019 | 383 | 0.150 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2019 | 209 | 0.150 |
Why?
|
| Autophagy | 2 | 2019 | 1349 | 0.140 |
Why?
|
| Thyroid Gland | 2 | 1994 | 1169 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2018 | 753 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3227 | 0.140 |
Why?
|
| Podocytes | 2 | 2019 | 389 | 0.140 |
Why?
|
| Dendritic Cells | 5 | 2018 | 2747 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 1346 | 0.140 |
Why?
|
| Autoimmunity | 2 | 2017 | 1355 | 0.140 |
Why?
|
| Muscle Relaxation | 1 | 1996 | 138 | 0.130 |
Why?
|
| Mice, Knockout | 12 | 2021 | 14455 | 0.130 |
Why?
|
| Wound Healing | 2 | 2019 | 2794 | 0.130 |
Why?
|
| Cloning, Molecular | 9 | 1999 | 4163 | 0.130 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2017 | 317 | 0.130 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1996 | 179 | 0.130 |
Why?
|
| Phosphoproteins | 4 | 1997 | 2445 | 0.130 |
Why?
|
| Indoleacetic Acids | 1 | 2015 | 44 | 0.130 |
Why?
|
| Meclizine | 1 | 2015 | 13 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2015 | 72 | 0.120 |
Why?
|
| 14-3-3 Proteins | 10 | 1997 | 221 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3594 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 696 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2022 | 4161 | 0.120 |
Why?
|
| Growth Substances | 2 | 1996 | 758 | 0.120 |
Why?
|
| DNA Damage | 3 | 2021 | 2464 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 89 | 0.120 |
Why?
|
| Proteins | 4 | 1997 | 5994 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 1998 | 853 | 0.120 |
Why?
|
| Regeneration | 5 | 2012 | 1516 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 481 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 3111 | 0.110 |
Why?
|
| Protective Agents | 1 | 2015 | 151 | 0.110 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18314 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2018 | 701 | 0.110 |
Why?
|
| Neuropeptides | 2 | 1996 | 950 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 8 | 1999 | 2743 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1363 | 0.110 |
Why?
|
| Intradermal Tests | 1 | 1993 | 43 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 1 | 2017 | 960 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2017 | 1250 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2879 | 0.110 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 11906 | 0.110 |
Why?
|
| Indans | 1 | 2013 | 92 | 0.110 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 280 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2021 | 1806 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2017 | 5988 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 1996 | 513 | 0.100 |
Why?
|
| Polyesters | 2 | 2016 | 373 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 931 | 0.100 |
Why?
|
| Renal Circulation | 1 | 2013 | 288 | 0.100 |
Why?
|
| Antineoplastic Agents | 4 | 2022 | 13634 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1441 | 0.100 |
Why?
|
| LLC-PK1 Cells | 3 | 2019 | 125 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2015 | 425 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 1119 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 4649 | 0.100 |
Why?
|
| Brain Stem | 1 | 1997 | 852 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2015 | 553 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2014 | 284 | 0.100 |
Why?
|
| Amino Acid Sequence | 16 | 1999 | 13400 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2015 | 614 | 0.090 |
Why?
|
| Microvessels | 1 | 2016 | 590 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2056 | 0.090 |
Why?
|
| Histamine | 1 | 1993 | 495 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 701 | 0.090 |
Why?
|
| Swine | 5 | 2019 | 5986 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 182 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2021 | 1857 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3722 | 0.090 |
Why?
|
| Molecular Sequence Data | 16 | 1999 | 17597 | 0.090 |
Why?
|
| Trachea | 1 | 1996 | 1094 | 0.090 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 332 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 1999 | 1984 | 0.090 |
Why?
|
| Mineral Oil | 1 | 2010 | 21 | 0.090 |
Why?
|
| Cyclin B2 | 1 | 2010 | 5 | 0.090 |
Why?
|
| DNA Repair | 1 | 2019 | 2048 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 1068 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 2 | 2021 | 268 | 0.080 |
Why?
|
| Apoptosis | 7 | 2020 | 9507 | 0.080 |
Why?
|
| RNA, Messenger | 10 | 2021 | 12772 | 0.080 |
Why?
|
| Male | 39 | 2021 | 363855 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 6 | 1994 | 4399 | 0.080 |
Why?
|
| Prednisone | 1 | 1994 | 1566 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1479 | 0.080 |
Why?
|
| Immunohistochemistry | 7 | 2018 | 11035 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3750 | 0.080 |
Why?
|
| Rats, Wistar | 7 | 2014 | 1886 | 0.080 |
Why?
|
| Fibroblast Growth Factor 1 | 3 | 1994 | 53 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2015 | 2495 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2013 | 8105 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2627 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 2425 | 0.070 |
Why?
|
| Ischemia | 3 | 2010 | 1904 | 0.070 |
Why?
|
| Immunosuppressive Agents | 4 | 2018 | 4213 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2010 | 777 | 0.070 |
Why?
|
| Glucose | 1 | 2019 | 4335 | 0.070 |
Why?
|
| Mitochondria | 3 | 2015 | 3675 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1762 | 0.070 |
Why?
|
| Base Sequence | 12 | 1999 | 12405 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 810 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 185 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 2429 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 959 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1592 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 1674 | 0.070 |
Why?
|
| Cell Proliferation | 6 | 2020 | 10431 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2019 | 2304 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 588 | 0.070 |
Why?
|
| T-Lymphocytes | 5 | 2020 | 10260 | 0.060 |
Why?
|
| Cell Movement | 2 | 2018 | 5194 | 0.060 |
Why?
|
| Transplantation, Homologous | 3 | 2020 | 4860 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3801 | 0.060 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2005 | 68 | 0.060 |
Why?
|
| Epithelium | 5 | 1996 | 1604 | 0.060 |
Why?
|
| Protein Kinases | 2 | 1991 | 1610 | 0.060 |
Why?
|
| RNA, Antisense | 1 | 2005 | 135 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 439 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2008 | 642 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 147 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4746 | 0.060 |
Why?
|
| Fluorouracil | 2 | 2022 | 1648 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2249 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4047 | 0.060 |
Why?
|
| Models, Biological | 1 | 2021 | 9446 | 0.060 |
Why?
|
| Disease Progression | 5 | 2021 | 13613 | 0.060 |
Why?
|
| Glycolysis | 2 | 2021 | 837 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2017 | 18964 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 321 | 0.060 |
Why?
|
| Organoids | 2 | 2021 | 741 | 0.060 |
Why?
|
| Cell Line | 8 | 2018 | 15545 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2006 | 2849 | 0.050 |
Why?
|
| Disulfides | 1 | 2005 | 461 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 393 | 0.050 |
Why?
|
| Respiration | 1 | 1990 | 1653 | 0.050 |
Why?
|
| Dogs | 1 | 2008 | 3825 | 0.050 |
Why?
|
| Inflammation | 5 | 2021 | 10857 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 608 | 0.050 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 9536 | 0.050 |
Why?
|
| Humans | 42 | 2022 | 766000 | 0.050 |
Why?
|
| Organ Transplantation | 1 | 2013 | 1172 | 0.050 |
Why?
|
| Protein Binding | 3 | 2008 | 9302 | 0.050 |
Why?
|
| Leucine | 2 | 1994 | 547 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2793 | 0.050 |
Why?
|
| Proteinuria | 1 | 2005 | 606 | 0.050 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 5791 | 0.050 |
Why?
|
| Cytokines | 5 | 2016 | 7425 | 0.050 |
Why?
|
| DNA | 6 | 1993 | 7192 | 0.050 |
Why?
|
| Signal Transduction | 6 | 2020 | 23600 | 0.050 |
Why?
|
| Phosphorylation | 5 | 2006 | 8290 | 0.050 |
Why?
|
| X Chromosome | 1 | 2005 | 819 | 0.050 |
Why?
|
| Nephritis | 2 | 2013 | 146 | 0.050 |
Why?
|
| Creatinine | 2 | 2019 | 1916 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 9237 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 477 | 0.050 |
Why?
|
| Cell Division | 4 | 1996 | 4467 | 0.050 |
Why?
|
| Mice, 129 Strain | 2 | 2012 | 368 | 0.050 |
Why?
|
| Magnesium | 2 | 2022 | 815 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2006 | 1074 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4482 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2015 | 4520 | 0.050 |
Why?
|
| Neoplasms | 2 | 2020 | 22336 | 0.050 |
Why?
|
| Radiation Chimera | 2 | 2015 | 216 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5454 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2411 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2021 | 147 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 2021 | 319 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 305 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 1994 | 951 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 126 | 0.040 |
Why?
|
| Protein Array Analysis | 2 | 2013 | 398 | 0.040 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 6492 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2021 | 230 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11858 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2020 | 183 | 0.040 |
Why?
|
| Granzymes | 1 | 2020 | 278 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2015 | 1336 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 1998 | 1885 | 0.040 |
Why?
|
| Sulfones | 1 | 2021 | 447 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3436 | 0.040 |
Why?
|
| Cattle | 6 | 1997 | 3801 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 3423 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 308 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1241 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 125 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2012 | 752 | 0.040 |
Why?
|
| Binding Sites | 4 | 2020 | 6002 | 0.040 |
Why?
|
| Phenotype | 3 | 2013 | 16712 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 924 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 1997 | 21 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 2018 | 175 | 0.040 |
Why?
|
| Microtomy | 1 | 1997 | 43 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 865 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2017 | 5019 | 0.040 |
Why?
|
| Cell Extracts | 1 | 1997 | 134 | 0.030 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 1996 | 31 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 2135 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 205 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2018 | 3159 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1999 | 4209 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1994 | 860 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5388 | 0.030 |
Why?
|
| Asthma | 3 | 2006 | 6268 | 0.030 |
Why?
|
| Endocytosis | 1 | 2021 | 952 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 459 | 0.030 |
Why?
|
| Folic Acid | 1 | 2003 | 1337 | 0.030 |
Why?
|
| Gene Expression | 5 | 2021 | 7581 | 0.030 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 1996 | 59 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2017 | 511 | 0.030 |
Why?
|
| Chromosomes | 1 | 1999 | 578 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 1748 | 0.030 |
Why?
|
| Carbachol | 1 | 1996 | 223 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1656 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2012 | 2864 | 0.030 |
Why?
|
| Transplantation Tolerance | 1 | 2021 | 641 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 872 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 1999 | 3831 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 193 | 0.030 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1996 | 109 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 456 | 0.030 |
Why?
|
| Sodium Cyanide | 1 | 2015 | 9 | 0.030 |
Why?
|
| Kinetics | 4 | 1996 | 6273 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2020 | 838 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1376 | 0.030 |
Why?
|
| Survival Rate | 2 | 2021 | 12821 | 0.030 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2015 | 27 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 938 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5879 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 740 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1999 | 1724 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2878 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2015 | 152 | 0.030 |
Why?
|
| Enzyme Activation | 4 | 2003 | 3584 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 780 | 0.030 |
Why?
|
| Microbubbles | 1 | 2016 | 137 | 0.030 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11642 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2015 | 173 | 0.030 |
Why?
|
| Vimentin | 1 | 1995 | 257 | 0.030 |
Why?
|
| Anodontia | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2015 | 198 | 0.030 |
Why?
|
| Lipoylation | 1 | 2015 | 87 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2015 | 322 | 0.030 |
Why?
|
| Lipocalins | 1 | 2015 | 162 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1001 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2015 | 330 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2120 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 252 | 0.030 |
Why?
|
| Mutagenesis | 2 | 2012 | 1227 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 3733 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2011 | 740 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1999 | 723 | 0.030 |
Why?
|
| Female | 18 | 2021 | 396158 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 411 | 0.030 |
Why?
|
| Vinblastine | 1 | 2015 | 482 | 0.030 |
Why?
|
| Galactose | 1 | 2015 | 299 | 0.030 |
Why?
|
| Pituitary Function Tests | 1 | 1993 | 24 | 0.030 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 1993 | 12 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 636 | 0.030 |
Why?
|
| Cyclic N-Oxides | 1 | 2013 | 71 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 204 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1999 | 852 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 1997 | 838 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 2 | 2010 | 212 | 0.030 |
Why?
|
| Esophagectomy | 1 | 2017 | 478 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 1994 | 289 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2062 | 0.030 |
Why?
|
| Japan | 2 | 2014 | 1414 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10736 | 0.030 |
Why?
|
| Lupus Nephritis | 1 | 2017 | 323 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 419 | 0.030 |
Why?
|
| Contrast Media | 2 | 2017 | 5329 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5775 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1494 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2667 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 773 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 539 | 0.030 |
Why?
|
| Protein Kinase C | 2 | 1994 | 1205 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 1994 | 228 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1993 | 355 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1993 | 590 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2013 | 275 | 0.030 |
Why?
|
| Whooping Cough | 1 | 1993 | 87 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 1055 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2001 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1994 | 493 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 462 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1997 | 853 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 1994 | 261 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1994 | 527 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4565 | 0.030 |
Why?
|
| RNA Interference | 1 | 2021 | 2825 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2269 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2010 | 0.020 |
Why?
|
| Substance P | 1 | 1993 | 331 | 0.020 |
Why?
|
| Spin Labels | 1 | 2013 | 334 | 0.020 |
Why?
|
| Fluoroacetates | 1 | 1991 | 13 | 0.020 |
Why?
|
| Plant Proteins | 1 | 1994 | 374 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1993 | 362 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 671 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 1994 | 408 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Halothane | 1 | 1991 | 200 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2324 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3051 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2018 | 1725 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2653 | 0.020 |
Why?
|
| Lymphokines | 1 | 1994 | 905 | 0.020 |
Why?
|
| Blotting, Northern | 4 | 1994 | 1546 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1994 | 674 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1992 | 348 | 0.020 |
Why?
|
| Oxidants | 1 | 2011 | 167 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1996 | 2677 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13482 | 0.020 |
Why?
|
| Time Factors | 4 | 2019 | 40100 | 0.020 |
Why?
|
| Arabidopsis | 1 | 1994 | 464 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2454 | 0.020 |
Why?
|
| Thyrotropin | 1 | 1994 | 834 | 0.020 |
Why?
|
| Thyroxine | 1 | 1994 | 665 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 833 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2020 | 2389 | 0.020 |
Why?
|
| Alopecia | 1 | 2015 | 415 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22231 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1603 | 0.020 |
Why?
|
| Ribosomes | 1 | 1993 | 495 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 1993 | 553 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2015 | 633 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2890 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 1077 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 410 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1996 | 0.020 |
Why?
|
| CHO Cells | 2 | 2005 | 1373 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9524 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1993 | 702 | 0.020 |
Why?
|
| Adenosine | 1 | 2014 | 813 | 0.020 |
Why?
|
| Cough | 1 | 1993 | 599 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1884 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 567 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3546 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4886 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2974 | 0.020 |
Why?
|
| Cricetinae | 2 | 2005 | 2413 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 7599 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2677 | 0.020 |
Why?
|
| Child, Preschool | 4 | 1994 | 42509 | 0.020 |
Why?
|
| Antibodies | 1 | 2016 | 2415 | 0.020 |
Why?
|
| Restriction Mapping | 3 | 1994 | 848 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2823 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 10060 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1715 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 1990 | 375 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 347 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3614 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1994 | 2161 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2144 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3942 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3907 | 0.020 |
Why?
|
| Insulin | 3 | 1997 | 6603 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 81542 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2825 | 0.020 |
Why?
|
| Cerebellum | 1 | 1994 | 1519 | 0.020 |
Why?
|
| Mutation | 4 | 2015 | 30208 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 964 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 4779 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1181 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3821 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 1142 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3445 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 2618 | 0.020 |
Why?
|
| Spirometry | 1 | 1990 | 929 | 0.020 |
Why?
|
| Child | 6 | 1994 | 80567 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2010 | 2921 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 659 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1505 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 932 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1404 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4262 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6611 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2005 | 27 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2005 | 34 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 2897 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2006 | 151 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2130 | 0.020 |
Why?
|
| Age Factors | 2 | 2012 | 18382 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2005 | 229 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 1426 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1832 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 2927 | 0.020 |
Why?
|
| Aged | 6 | 2022 | 171161 | 0.020 |
Why?
|
| Cholesterol | 1 | 1994 | 2901 | 0.020 |
Why?
|
| Chromatin | 1 | 1997 | 2980 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 771 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 287 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 2 | 1997 | 100 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3089 | 0.010 |
Why?
|
| Peptides | 1 | 1996 | 4338 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 674 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1888 | 0.010 |
Why?
|
| Mitosis | 1 | 2010 | 1175 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4765 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1490 | 0.010 |
Why?
|
| Sequence Alignment | 2 | 1999 | 2175 | 0.010 |
Why?
|
| Transfection | 2 | 2005 | 5739 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 3079 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 17070 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1993 | 1168 | 0.010 |
Why?
|
| Brain | 5 | 1997 | 27171 | 0.010 |
Why?
|
| Cricetulus | 1 | 2005 | 807 | 0.010 |
Why?
|
| Homeostasis | 1 | 2015 | 3338 | 0.010 |
Why?
|
| Consensus Sequence | 2 | 1994 | 363 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1991 | 1935 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2012 | 2115 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2003 | 92 | 0.010 |
Why?
|
| Middle Aged | 6 | 2021 | 223025 | 0.010 |
Why?
|
| Neurons | 2 | 1994 | 9520 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1991 | 1996 | 0.010 |
Why?
|
| Calcimycin | 1 | 2003 | 214 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2003 | 102 | 0.010 |
Why?
|
| Tunicamycin | 1 | 2003 | 108 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 1607 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6361 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2003 | 147 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3274 | 0.010 |
Why?
|
| Clostridium | 1 | 1983 | 100 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3077 | 0.010 |
Why?
|
| Gynecomastia | 1 | 1983 | 87 | 0.010 |
Why?
|
| Sirolimus | 1 | 2010 | 1541 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11202 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2006 | 940 | 0.010 |
Why?
|
| Splenic Diseases | 1 | 1983 | 91 | 0.010 |
Why?
|
| Calreticulin | 1 | 2003 | 111 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5752 | 0.010 |
Why?
|
| Melanoma | 1 | 2020 | 5695 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3586 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 472 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2003 | 330 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 1992 | 127 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 1498 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1983 | 457 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1983 | 264 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 2406 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15882 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2020 | 12128 | 0.010 |
Why?
|
| Aging | 2 | 1996 | 8722 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 634 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1993 | 4910 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 2077 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 693 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 297 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1107 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8925 | 0.010 |
Why?
|
| Abscess | 1 | 1983 | 605 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1992 | 1430 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 812 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2197 | 0.010 |
Why?
|
| Transcriptional Elongation Factors | 1 | 1999 | 169 | 0.010 |
Why?
|
| Calcium | 2 | 2003 | 5770 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1997 | 67 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 6057 | 0.010 |
Why?
|
| Spodoptera | 1 | 1997 | 140 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2012 | 2885 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 1997 | 19 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1997 | 137 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1997 | 169 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2729 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2223 | 0.010 |
Why?
|
| Cell Nucleolus | 1 | 1997 | 156 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 240 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1997 | 695 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1999 | 1076 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 316 | 0.010 |
Why?
|
| Software | 1 | 1990 | 4463 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1996 | 244 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1997 | 558 | 0.010 |
Why?
|
| Casein Kinase II | 1 | 1996 | 120 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1996 | 179 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 527 | 0.010 |
Why?
|
| Adolescent | 3 | 1993 | 88808 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 1996 | 161 | 0.010 |
Why?
|
| Gene Library | 1 | 1997 | 1065 | 0.010 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 1994 | 17 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1997 | 563 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 489 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1994 | 283 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 416 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1061 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 223106 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1994 | 290 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 484 | 0.010 |
Why?
|
| Dwarfism, Pituitary | 1 | 1993 | 39 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1993 | 197 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21072 | 0.010 |
Why?
|
| Thymidine | 1 | 1993 | 294 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1993 | 94 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1983 | 1471 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 3405 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1993 | 422 | 0.010 |
Why?
|
| Dwarfism | 1 | 1993 | 137 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1994 | 748 | 0.010 |
Why?
|
| Trifluoroacetic Acid | 1 | 1991 | 5 | 0.010 |
Why?
|
| Liver | 2 | 1999 | 7558 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 420 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1993 | 241 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 20135 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 772 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1996 | 2469 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 1993 | 194 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1159 | 0.010 |
Why?
|
| DNA Probes | 1 | 1992 | 541 | 0.010 |
Why?
|
| Biogenic Monoamines | 1 | 1991 | 50 | 0.010 |
Why?
|
| Infant | 1 | 1993 | 36424 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 1983 | 1912 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 9600 | 0.010 |
Why?
|
| Autoradiography | 1 | 1991 | 723 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2091 | 0.010 |
Why?
|
| Biological Assay | 1 | 1993 | 626 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14644 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6101 | 0.010 |
Why?
|
| Acetamides | 1 | 1991 | 260 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 3070 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1056 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1991 | 825 | 0.010 |
Why?
|
| Culture Media | 1 | 1991 | 889 | 0.010 |
Why?
|
| Genes | 1 | 1993 | 1824 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1991 | 697 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1991 | 1644 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1993 | 731 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1994 | 1440 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1991 | 1527 | 0.000 |
Why?
|
| Reference Values | 1 | 1993 | 4909 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1997 | 2328 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5125 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1993 | 2156 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 4616 | 0.000 |
Why?
|
| RNA | 1 | 1993 | 2715 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1994 | 3499 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1991 | 1810 | 0.000 |
Why?
|
| Placenta | 1 | 1992 | 1726 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1997 | 4354 | 0.000 |
Why?
|
| Metronidazole | 1 | 1983 | 237 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 4423 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1993 | 2513 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 21509 | 0.000 |
Why?
|
| Feces | 1 | 1983 | 1503 | 0.000 |
Why?
|
| Pregnancy | 1 | 1992 | 30227 | 0.000 |
Why?
|
| Risk Factors | 1 | 1996 | 74838 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1983 | 20698 | 0.000 |
Why?
|